Literature DB >> 20022939

Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone.

Christiane Gaudreau, René Lecours, Johanne Ismaïl, Simon Gagnon, Louise Jetté, Michel Roger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022939     DOI: 10.1093/jac/dkp458

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  17 in total

1.  Antimicrobial susceptibilities of group B streptococcus isolates from prenatal screening samples.

Authors:  Benjamin R Berg; Jeana L Houseman; Zachary E terSteeg; William D LeBar; Duane W Newton
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

2.  Characterization of multidrug-resistant group B streptococci with reduced penicillin susceptibility forming small non-Beta-hemolytic colonies on sheep blood agar plates.

Authors:  Hirotsugu Banno; Kouji Kimura; Yosuke Tanaka; Hiromitsu Kitanaka; Wanchun Jin; Jun-ichi Wachino; Keiko Yamada; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

3.  A Single Amino Acid Replacement in Penicillin-Binding Protein 2X in Streptococcus pyogenes Significantly Increases Fitness on Subtherapeutic Benzylpenicillin Treatment in a Mouse Model of Necrotizing Myositis.

Authors:  Randall J Olsen; Luchang Zhu; James M Musser
Journal:  Am J Pathol       Date:  2020-05-11       Impact factor: 4.307

4.  Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility.

Authors:  Noriyuki Nagano; Yukiko Nagano; Masami Toyama; Kouji Kimura; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

5.  Reduced In Vitro Susceptibility of Streptococcus pyogenes to β-Lactam Antibiotics Associated with Mutations in the pbp2x Gene Is Geographically Widespread.

Authors:  James M Musser; Stephen B Beres; Luchang Zhu; Randall J Olsen; Jaana Vuopio; Hanne-Leena Hyyryläinen; Kirsi Gröndahl-Yli-Hannuksela; Karl G Kristinsson; Jessica Darenberg; Birgitta Henriques-Normark; Steen Hoffmann; Dominque A Caugant; Andrew J Smith; Diane S J Lindsay; David M Boragine; Timothy Palzkill
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

6.  Molecular Characteristics of Group B Streptococci Isolated from Adults with Invasive Infections in Japan.

Authors:  Miyuki Morozumi; Takeaki Wajima; Misako Takata; Satoshi Iwata; Kimiko Ubukata
Journal:  J Clin Microbiol       Date:  2016-08-24       Impact factor: 5.948

7.  Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy.

Authors:  Jean Longtin; Christie Vermeiren; Dea Shahinas; Gurdip Singh Tamber; Allison McGeer; Donald E Low; Kevin Katz; Dylan R Pillai
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

8.  High isolation rate and multidrug resistance tendency of penicillin-susceptible group B Streptococcus with reduced ceftibuten susceptibility in Japan.

Authors:  Hirotsugu Banno; Kouji Kimura; Tomomi Seki; Wanchun Jin; Jun-Ichi Wachino; Keiko Yamada; Noriyuki Nagano; Yoshichika Arakawa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-17       Impact factor: 3.267

9.  Clinical and bacterial features of Group B streptococci with reduced penicillin susceptibility from respiratory specimens: a case-control study.

Authors:  Naoya Nishiyama; Takeshi Kinjo; Kohei Uechi; Gretchen Parrott; Masashi Nakamatsu; Masao Tateyama; Jiro Fujita
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-08-12       Impact factor: 3.267

10.  Isolation of Group A Streptococci with Reduced In Vitro β-Lactam Susceptibility Harboring Amino Acid Substitutions in Penicillin-Binding Proteins in Japan.

Authors:  Tsubasa Ikeda; Rihito Suzuki; Wanchun Jin; Jun-Ichi Wachino; Yoshichika Arakawa; Kouji Kimura
Journal:  Antimicrob Agents Chemother       Date:  2021-10-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.